Document is current
Any future updates will be listed below
-
Authors
Huber, Sandra https://orcid.org/0009-0009-4441-9667
Hutter, Stephan https://orcid.org/0000-0003-2432-8898
Meggendorfer, Manja https://orcid.org/0000-0002-9038-3265
Pohlkamp, Christian
Haferlach, Torsten https://orcid.org/0000-0003-0196-2837
Summerer, Isolde https://orcid.org/0009-0002-9144-010X
- License Information
-
More Information
Article History
Received: 3 February 2026
Revised: 1 April 2026
Accepted: 28 April 2026
First Online: 9 May 2026
Competing interests
: TH declares part ownership of MLL Munich Leukemia Laboratory. SH, StH, MM, CP and IS are employed by the MLL.
: All patients gave their informed consent for genetic analyses and the use of laboratory results for research purposes. The study adhered to the tenets of the Declaration of Helsinki and was approved by the laboratory´s institutional review board and the Ethics Committee of the Bavarian Medical Association for the use of archived DNA/RNA samples and associated clinical information. The clinical data were retrieved, and the samples were collected and analysed with the endorsement of the Ethics Committee of the Bavarian Medical Association.
